Explore the Future of Cancer Detection and Women's Health with UBC Researchers!
Learn more about cancer research.
About The Study
Are you aware that an estimated 1 in 2 women will face a cancer diagnosis in their lifetime? In response to these alarming statistics, the University of British Columbia is spearheading the RESToRE study, a groundbreaking initiative aiming to transform early cancer screening and prevention. This study examines the feasibility and acceptability of innovative approaches, delving into the complex interplay of cancer risk factors.
The overarching goal is to enhance screening precision, improve accessibility to prevention measures, and alleviate the strain on health resources. Join researchers as they reshape the landscape of cancer prevention and make a lasting impact on women's health, today!
Who Can Participate?
- Must be postmenopausal
- Must not have had a period for at least 3 years
- Must not currently be on any hormonal therapy or using an intrauterine device (IUD)
- Must not have had a hysterectomy
- Must not have recently experienced any abnormal uterine bleeding (menstrual bleeding, including spotting, after menopause)
- Must not currently be receiving any chemotherapy or pelvic radiation therapy
- Must be able to virtually participate in this study for 7 virtual study visits for approximately 2 months
Why Participate?
- Participants have the chance to take part in a 4-week nutrition and exercise program with a coach.
- Participants will receive $20 electronic gift card to account for any out-of-pocket costs.
- Participants may receive an early diagnosis of an underlying pathology.
- Participants will be contributing valuable information that may benefit the future of women’s health.
- Participants will be helping to advance prevention research on uterine cancer.
More Study Details
The study team will explain the research in its entirety but some details are:
- Once a participant provides consent, the study coordinator will help them download a mobile app called MyCap, to keep track of their participation in the study. Non-app communication is available via email or phone calls if preferred. In addition, our study physicians will be connecting with the indicated primary care provider, if applicable, to ensure they are aware of participation in the study and address any concerns.
- Participants will take part in the Progesterone Challenge Test. Once researchers receive confirmation that a primary care provider or a gynecologist is supporting their participation, researchers will ask that they contact them to schedule an appointment. During the medical appointment, the doctor will explain the Progesterone Challenge Test, review what to expect, and prescribe an oral medication (medroxyprogesterone acetate). Please indicate when this prescription is received on MyCap, and do not start the Progesterone Challenge Test until the next step is completed (at-home tampon and vaginal swabs).
- Once the at-home vaginal sample collection is completed and the samples are sent back, the next step will be to start the Progesterone Challenge Test. Participants will be asked to take the prescribed oral medication once a day, for ten (10) days. Researchers will send reminders through the MyCap app, which will also allow participants to track the days of the Progesterone Challenge Test.
Meet the Lead Researchers
Aline Talhouk
Dr. Talhouk is an assistant professor in the Department of Obstetrics & Gynaecology and the director of data science and informatics at OVCARE, BC’s ovarian and gynecological cancer research program...She completed her PhD in Statistics at the University of British Columbia in 2013 with a focus on computational statistics and machine learning. Since then, she has been working on developing and implementing predictive models to improve patient care in women’s health and oncology. Her research spans the cancer continuum from prevention to survivorship. She is also interested in the ethics of data sharing and the impact of digital health and AI modelling on fairness and privacy.
Jessica McAlpine
Dr. Jessica McAlpine is an incoming Tier 1 Canada Research Chair in Molecular Classification of Gynecologic Cancers.., Dr. Chew Wei Chair in Gynecologic Oncology, Co-Head of the Division of Gynecologic Oncology, and Professor at the University of British Columbia in the Department of Obstetrics and Gynecology. As a surgeon-scientist practicing at BC Cancer and Vancouver General Hospital, she has built a research program focused on the development and application of molecular tools to stratify risk and direct care for people with gynecological cancers. Her research in the molecular triage of gynecological cancers has resulted in changes to practice and has led to international clinical trials in endometrial, vulvar, and ovarian cancers.
Andrea Neilson
Dr. Andrea Neilson is a Gynecologic Oncologist and a Miller Mindell Research Fellow in Vancouver... She completed her medical degree and residency at the University of Alberta and her Fellowship in Gynecologic Oncology at the University of British Columbia. Her investigational focus is gynecologic cancer, with a special focus on translational research; helping to bridge the gap between the bench and the clinic. Her current projects involve molecular profiling of endometrial and endometriosis-related ovarian cancers as well as early detection of uterine cancer. Dr. Neilson is proud to be a collaborator with the world-class researchers within the Uterine Health Research Lab.
Meet the Lead Researchers
Aline Talhouk
Dr. Talhouk is an assistant professor in the Department of Obstetrics & Gynaecology and the director of data science and informatics at OVCARE, BC’s ovarian and gynecological cancer research program...She completed her PhD in Statistics at the University of British Columbia in 2013 with a focus on computational statistics and machine learning. Since then, she has been working on developing and implementing predictive models to improve patient care in women’s health and oncology. Her research spans the cancer continuum from prevention to survivorship. She is also interested in the ethics of data sharing and the impact of digital health and AI modelling on fairness and privacy.
Jessica McAlpine
Dr. Jessica McAlpine is an incoming Tier 1 Canada Research Chair in Molecular Classification of Gynecologic Cancers.., Dr. Chew Wei Chair in Gynecologic Oncology, Co-Head of the Division of Gynecologic Oncology, and Professor at the University of British Columbia in the Department of Obstetrics and Gynecology. As a surgeon-scientist practicing at BC Cancer and Vancouver General Hospital, she has built a research program focused on the development and application of molecular tools to stratify risk and direct care for people with gynecological cancers. Her research in the molecular triage of gynecological cancers has resulted in changes to practice and has led to international clinical trials in endometrial, vulvar, and ovarian cancers.
Andrea Neilson
Dr. Andrea Neilson is a Gynecologic Oncologist and a Miller Mindell Research Fellow in Vancouver... She completed her medical degree and residency at the University of Alberta and her Fellowship in Gynecologic Oncology at the University of British Columbia. Her investigational focus is gynecologic cancer, with a special focus on translational research; helping to bridge the gap between the bench and the clinic. Her current projects involve molecular profiling of endometrial and endometriosis-related ovarian cancers as well as early detection of uterine cancer. Dr. Neilson is proud to be a collaborator with the world-class researchers within the Uterine Health Research Lab.
Study Details and Location
Research Site:
University of British Columbia
Location:
This study is conducted virtually across British Columbia
Lead Researcher:
Aline Talhouk, Jessica McAlpine, and Andrea Neilson
Ethics Committee:
This study has been reviewed and approved by the UBC/BC Cancer Research Ethics Board
MEET THE RESEARCH CENTER
University of British Columbia
The University of British Columbia is a global centre for teaching, learning, and research, consistently ranked among the top 50 public universities in the world. ..UBC embraces innovation and transforms ideas into action. Since 1915, UBC has been opening doors of opportunity for people with the curiosity, drive, and vision to shape a better world.
We Have You Covered
Qualified Health Professionals
Ethics Approved
Trained Staff
Qualified health professionals will monitor your health as it relates to the study.
This trial has been reviewed and approved by an independent ethics committee.
All research staff that are running this trial have been trained in GCP, which assures that the rights, safety, and well-being of research subjects are protected and respected.
National Privacy Standards
Encrypted Data
We follow all established national privacy standards used in all doctors' offices, hospitals and other businesses where personal medical information is stored.
All data you provide us is encrypted and stored safely and securely in accordance with security and privacy rules.
Your Rights
Informed Consent Before Participation
Withdraw At Any Time
Strictly Confidential
Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
You will receive a detailed outline of all details of the study, including treatment, risks and procedures, and given the chance to ask questions to study staff, before you decide whether to participate.
Ready to make a
difference?
Is this study not for you?
Join our new trial email list to be notified of new trials that could be a fit for you.
© 2024 Trialfacts. All Rights Reserved. | (415) 704-1575 USA | (07) 3054 7094 AUS support@trialfacts.com | Privacy Policy